Growth factor-induced cell migration underlies various physiological and pathological processes. The mechanisms by which growth factors regulate cell migration are not completely understood. 
Growth factor-induced cell migration plays essential roles in organism development, physiological functions, and pathological disease processes (1, 2) . In wound healing, fibroblast cells migrate into the wound site. Once within the wound site, fibroblasts proliferate and lay down a new collagen-rich connective tissue matrix (3) . Vascular smooth muscle cell migration induced by platelet-derived growth factor (PDGF) 1 and other factors contributes to the pathophysiology of intimal hyperplasia and is an essential component of the intimal process that leads to recurrent stenosis (4) . The invasion and metastasis of tumor cells also require cell migration (5) . Solid tumors, which account for more than 85% of cancer mortality, require blood vessels for growth, and many new cancer therapies are directed against the tumor vasculature, a process involving growth factor-induced cell migration (6) . Ca 2ϩ is a critical second messenger for a wide range of physiological processes, including the electrical excitability of neurons, muscle contraction, cellular secretion, and gene expression (7) . Ca 2ϩ also plays a regulatory role in cell migration such as in neutrophils, eosinophils, smooth muscle cells, and neurons (8 -12) . Cell migration is a sequential and interrelated multistep process (2) . It involves the formation of lamellipodia/ membrane protrusion at the front edge, cycles of adhesion and detachment, cell body contraction, and tail retraction. In migrating cells, Ca 2ϩ concentration is high at the rear end and low at the front leading edge (9, (12) (13) (14) .
Increase of cellular Ca 2ϩ levels is brought about by either Ca 2ϩ release from intracellular stores or Ca 2ϩ influx through plasma membrane Ca 2ϩ or other cation channels (7) . Both Ca 2ϩ release and Ca 2ϩ influx have been linked to cell migration depending on cell-types and stimuli (10, 12, 15, 16) . In some cases, it is the induction of a Ca 2ϩ transient that is important for cell migration irrespective of the Ca 2ϩ source (8, 16) . Among the membrane channels are the voltage-gated L-type Ca 2ϩ channels, which selectively allow the flow of Ca 2ϩ ions down an electrochemical gradient, from a high concentration outside the cell to a low concentration inside the cell, to increase cytosolic Ca 2ϩ level (17) . These L-type Ca 2ϩ channel proteins are expressed in excitable cells such as neurons and cardiac myocytes (17) . Indeed, L-type Ca 2ϩ channels have been genetically implicated in controlling neuronal migration in Caenorhabditis elegans (18) and axonal guidance in Xenopus spinal neurons (19) . Although cellular Ca 2ϩ is critical for fibroblast cell migration, the source of the Ca 2ϩ increase and the mechanism by which Ca 2ϩ plays its role in controlling fibroblast cell migration are not clear.
Here we use mouse embryonic fibroblasts (MEFs) to study the potential role of voltage-gated L-type Ca 2ϩ channels in growth factor-induced cell migration. We found that Ca 2ϩ release from intracellular stores is not essential for PDGF-induced MEF cell migration. and were cultured in DMEM supplemented with 10% FBS and 2 mM glutamine (20) . PDGF-BB was from Oncogene Research Products. BAPTA-AM (1,2-bis [aminophenoxy] ethane-N,N,NЈ,NЈ-tetraacetic acid), W7, and ML-7 were from Calbiochem.
In Vitro Wound-healing Cell Migration Assay-Cell migration assays were performed as described previously (21) . Cells were allowed to form a confluent monolayer in a 24-well plate coated with gelatin before wounding. The wound was made by scraping a conventional pipette tip across the monolayer. The migration was induced by adding medium supplemented with or without 10% FBS, 20 ng/ml PDGF or 20 ng/ml epidermal growth factor. For MEF cells, it typically took 8 -10 h for the wound to close. When the wound for the positive control closed, cells were fixed with 3.7% formaldehyde and stained with crystal violet staining solution.
Boyden Chamber Cell Migration Assay-MEF cells (5 ϫ 10 4 ) suspended in DMEM were added to the upper chamber of an insert coated with gelatin (6.5-mm diameter, 8-m pore size, Becton Dickinson), and the chamber was placed in 24-well dishes containing DMEM with or without 10% FBS, 40 ng/ml PDGF or 40 ng/ml epidermal growth factor. When used, inhibitors were added to both chambers. Migration assays were carried out for 4 h and cells were fixed with 3.7% formaldehyde. Cells were stained with crystal violet staining solution, and cells on the upper side of the insert were removed with a cotton swab. Three randomly selected fields (10ϫ objective) were photographed, and the migrated cells were counted. The migration was expressed as either the average number of migrated cells in a field or as percentage of migrated cells. Percentage was calculated with the formula P ϭ 100 , 2.5 mM probenecid (Sigma), and 0.1% bovine serum albumin (Sigma). The calcium-sensitive dye, Fluo-3 (Molecular Probes), was dissolved in dimethyl sulfoxide (Me 2 SO), mixed with an equal volume of 20% Pluronic-127 (Sigma), and diluted in standard solution plus 1% bovine serum albumin to a final concentration of 4 M. Cells were washed with standard solution and incubated with 100 l of 4 M Fluo-3/well for 45 min at 22°C followed by 15 min at 37°C. Cells were then washed three times with standard solution (200 l/well) on ice. Finally, 100 l of standard solution was added per well, and cells were incubated at 37°C for 15 min before the assay. The change in fluorescence was monitored using a Fluorescent Ascent FL fluorometer. Western blots were performed as described previously (23) .
Immunofluorescence Microscopy-Immunofluorescence microscopy was performed as described previously (24) . Cells cultured on gelatincoated coverslips were fixed with 3.7% formaldehyde in PBS for 10 min at room temperature, permeabilized with 0.1% Triton X-100 in PBS for 3 min, and blocked with 1% bovine serum albumin in PBS for 1 h. Cells were then incubated with primary antibodies at appropriate dilutions (1:100 for rabbit anti-pSer-19 MLC (from Cell Signaling); 1:4000 for rabbit anti-␣ 1c subunit of L-type Ca 2ϩ channels (from Alomone Labs)) for 2 h. After washing with PBS, cells were incubated with Alexa 488-conjugated anti-rabbit IgG for 60 min. For visualization of actin filaments, Texas Red-conjugated phalloidin (Molecular Probes) was added during the incubation with secondary antibody. MEF cells were fixed with 3.7% formaldehyde and permeabilized with 0.1% Triton X-100. Cells were then incubated with 25 g/ml Cy5 NHS (Amersham Biosciences) in PBS, pH 8.0, at room temperature for 30 min. After incubation, cells were washed with PBS, blocked with 1% bovine serum albumin, and stained with appropriate antibodies. pMLC/total protein ratio images were obtained with Metamoph software.
RESULTS

Ca
2ϩ Release Is Not Essential for PDGF-induced MEF Cell Migration-In MEF cells, stimulation with PDGF induced cell migration, as measured by both in vitro wound-healing assay ( Fig. 1A) and Boyden chamber assay (Fig. 1B) . This migration was blocked by treatment with the membrane-permeable Ca 2ϩ chelator, BAPTA-AM, indicating that Ca 2ϩ plays an indispensable role in PDGF-induced MEF cell migration (Fig. 1B) . However, Ca 2ϩ elevation by itself was not sufficient because the Ca 2ϩ ionophore, ionomycin, treatment did not induce cell migration (data not shown). To investigate the source of Ca 2ϩ increase in fibroblast cells after PDGF treatment, we examined the significance of Ca 2ϩ release and Ca 2ϩ influx in fibroblast cell migration. Growth factor receptor tyrosine kinase-induced Ca 2ϩ responses usually consist of two phases, an early transient peak that is due to Ca 2ϩ release from internal stores, and a late sustained plateau that is due to Ca 2ϩ influx (7) . Ca 2ϩ release is initiated by the binding of inositol 1,4,5-triphosphate to its receptor on the endoplasmic reticulum. Inositol 1,4,5-triphosphate is generated by the hydrolysis of phosphatidyl inositol 4,5-bisphosphate by PLC. In response to growth factors, PLC␥ is responsible for the Ca 2ϩ release (25) . In fibroblast cells, PLC␥1 is the main expressed PLC␥ isoform (20) . Indeed, in PLC␥1
Ϫ/Ϫ fibroblast cells, PDGF-induced Ca 2ϩ release from internal stores was abolished, whereas Ca 2ϩ influx was intact ( Fig. 1, C (Fig. 3A) . Immunostaining of MEF cells with anti-L-type Ca 2ϩ channel antibodies revealed membrane staining (Fig. 3B) . L-type Ca 2ϩ channel proteins are uniformly distributed on the plasma membrane (including the front as well as the tail of a migrating MEF cell). The staining at the tail membrane was overshadowed by the strong perinuclear channel blocker nimodipine decreased the late sustained phase of the PDGF-induced Ca 2ϩ elevation while having no effect on the initial Ca 2ϩ peak (Fig. 3D) . Fourth, L-type Ca 2ϩ channels are required for PDGF-induced MEF cell migration. Pretreatment of MEF cells with nimodipine decreased PDGF-induced cell migration (Fig. 3, E and F) . Furthermore, epidermal growth factor-induced MEF cell migration was also blocked by nimodipine, indicating that L-type Ca 2ϩ channels are generally involved in growth factor-induced fibroblast migration (data not shown). Together, the above data strongly demonstrate that PDGF-induced fibroblast cell migration depends on L-type (Fig. 4A ). This Rac1(G12V)-promoted cell migration was abolished by Ca 2ϩ influx blocker Ni 2ϩ (Fig. 4B) . Furthermore, 1 h after making the wound in an in vitro wound-healing assay, lamellipodia (a Rac-dependent phenomenon) were seen along the wound edge of EGTA-, Ni 2ϩ -, or nimodipine-treated cells in the presence of PDGF ( Fig. 4C ; data with Ni 2ϩ not shown). These data suggested that the Ca 2ϩ signal acts downstream of or in parallel to Rac and that Ca 2ϩ is not required for the formation of lamellipodia and membrane protrusions at the leading edge of migrating fibroblasts.
Because calmodulin is a major mediator of Ca 2ϩ signaling, we tested whether calmodulin mediates Ca 2ϩ regulation of cell migration. Treatment of MEF cells with calmodulin antagonist W7 significantly inhibited PDGF-and serum-induced cell migration (Fig. 4, D and E) . 
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ing peptide blocked PDGF-and serum-induced cell migration (Fig. 4, F and G) . Among the calmodulin effectors, calcineurin was reported to be involved in integrin turnover. Inhibition of calcineurin blocked neutrophil migration, and this blockage could be reversed by the addition of integrin antibodies (28, 29) . However, in MEF cells, calcineurin inhibitor cyclosporin A had no effect on PDGF-induced MEF migration, whereas control experiments showed that at this concentration cyclosporin A inhibited calcineurin activity effectively (data not shown).
Another calmodulin target is MLCK, which phosphorylates the regulatory light chain of myosin II MLC and thus activates myosin II (30) . The essential role of myosin II in actin cytoskeletal rearrangement and cell migration has long been appreciated (31) . The contraction of actomyosin filaments contributes to the cell body movement and tail retraction in migrating cells (1, 32) . Myosin II deficiency and myosin II inhibitors impaired Dictyostelium and neutrophil migration (33, 34) . Moreover, in a number of cell types including leukocytes, lymphocytes, and Dictyostelium, myosin II has been reported to localize to the rear end of migrating cells (33, 34) . Rho and its effector Rho showed that serum (10% FBS)-induced MEF cell migration was blocked by the addition of EGTA to the culture medium. E, the in vitro wound-healing assay showed that both PDGF-and serum-induced MEF cell migration was blocked by addition of Ni 2ϩ to the culture medium. F, the in vitro wound-healing assay showed that both PDGF-and serum-induced MEF cell migration was blocked by addition of La 3ϩ . G-I, Ni 2ϩ blocked seruminduced 4T1 mouse breast tumor cell migration (G), human MDA-MB-231 breast tumor cell migration (H), human umbilical vein endothelial cell migration (I). Data are representative of three experiments.
kinase are considered to be the major regulators of myosin II in cell migration. Rho kinase could activate myosin II by either directly phosphorylating MLC, or by inhibiting MLC phosphatase thereby indirectly elevating the MLC phosphorylation level (35) . However, the role of Rho and Rho kinase in cell migration is cell-type-dependent (36) . In fast migrating cells such as macrophages and neutrophils, Rho and Rho kinase appear to be required for cell polarization and migration (35) . In slow migrating cells, such as fibroblasts, Rho and Rho kinase appear to inhibit migration. Indeed, Rho inhibitor C3 toxin did not decrease MEF cell migration (data not shown), and Rho kinase inhibitor Y-27632 even promoted MEF cell migration (Fig. 5A) , confirming that Rho and Rho kinase are not essential for promoting fibroblast migration. Therefore, we examined the role of MLCK in PDGF-induced cell migration. Treatment of MEF cells with MLCK inhibitor ML-7 markedly inhibited PDGF-and serum-induced migration (Fig. 5, B and C) . These data suggested that MLCK acts downstream of calmodulin mediating Ca 2ϩ control of cell migration. To further investigate the relationship between Ca 2ϩ influx and MLC phosphorylation, we examined the distribution of phosphorylated MLC in migrating cells. As shown in Fig. 6A , there were two areas of phosphorylated-MLC staining in polarized migrating cells, postlamellipodia staining and trailing tail staining. Strong staining of phosphorylated-MLC was observed in the actin assembly immediately behind the lamellipodia of polarized migrating cells (Fig. 6A) . The other area of phosphorylated-MLC staining was in the rear end of the cell body, especially the trailing tail of polarized cells (Fig. 6A) . This staining pattern of phosphorylated-MLC was also confirmed by the ratio imaging of phosphorylated-MLC over total proteins (Fig. 6A) . During migration, cells can adopt two morphologies. In the first morphology, membrane protrusion at the leading edge and strong adhesion at the rear force cells to adopt an elongated shape with a trailing tail (Fig. 6A) . In these cells, extension of the front edge occurs as a distinct phase from retraction of the rear end (37) . When elongation tension reaches a threshold, the trailing tail detaches from the substratum and retracts (37) . After retraction, the cell adopts the second, fan-shaped morphology (Fig. 6B) . The trailing tail phosphorylated-MLC staining was only observed in the elongated migrating cells. In the fan-shaped cells, only postlamellipodia staining of phosphorylated-MLC was observed (Fig.  6B) . When Ca 2ϩ influx was blocked with Ni 2ϩ , the strong postlamellipodia staining of phosphorylated-MLC remained, but no or weak trailing tail staining was observed in most cells (Fig. 6C) . In the untreated control group (Fig. 6A) , 87% (41 of 47) of the observed elongated migrating cells displayed strong trailing tail staining with anti-phosphorylated MLC antibody, whereas the remaining 6 cells showed weak trailing tail staining of phosphorylated-MLC. In Ni 2ϩ -treated group (Fig. 6C) , 39 of the 47 observed elongated cells showed no or weak tail staining of phosphorylated-MLC, whereas the remaining 17% (8 of 47) of cells showed strong trailing edge staining. Moreover, treatment with MLCK inhibitor ML-7 reduced the staining of phosphorylated-MLC at the tail, without significant effect on the staining at the front (Fig. 6D) . Taken together, our data demonstrated that Ca 2ϩ influx regulates the phosphorylation of MLC at the trailing tail and thus contributes to the trailing tail contraction.
DISCUSSION
Our results have demonstrated that L-type Ca 2ϩ channels are required for MEF cell migration. There are two unexpected findings here. One is that voltage-gated L-type Ca 2ϩ channels play an important role in fibroblast cells. Previously, voltagegated L-type Ca 2ϩ channel proteins were thought to be mainly expressed in excitable cells such as neurons and muscle cells (38) . Our data revealed that these channel proteins are expressed in fibroblast cells and play an essential role in fibro- 
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blast cell migration. Recently the multiorgan disorder Timothy syndrome was identified to be caused by an L-type Ca 2ϩ channel missense mutation, which leads to the loss of voltage-dependent channel inactivation (39) . The dysfunction includes lethal arrhythmias, webbing of fingers and toes, congenital heart disease, immune deficiency, intermittent hypoglycemia, cognitive abnormalities, and autism (39) . Furthermore, another recent report has shown that L-type Ca 2ϩ channels are essential for T lymphocyte functions in mice (40) . These recent studies revealed a much wider expression pattern for L-type Ca 2ϩ channel proteins, consistent with our observation here. The second unexpected finding reported here is that L-type Ca 2ϩ channels, instead of Rho and Rho kinase, control the contraction of the trailing end of migrating fibroblasts. Rho and Rho kinase have long been suggested to be responsible for the actomyosin contraction at the trailing tail in fast migrating cells such as neutrophils and macrophages (35, 36) . Our data clearly demonstrate that Ca 2ϩ influx through L-type Ca 2ϩ channels is responsible for the trailing tail MLC phosphorylation in slow moving fibroblast cells. It is possible that in other slow migrating cell types such as epithelial cells, Ca 2ϩ influx rather than Rho and Rho kinase might be responsible for the rear end contraction. Consistent with this possibility, we have shown that mouse breast tumor cells and human breast tumor cells (both are epithelial origin) were sensitive to Ca 2ϩ influx blockers (Fig. 2) .
Through calmodulin and MLCK, Ca 2ϩ influx modulates the phosphorylation of MLC at the trailing tail of migrating cells, and thus the actomyosin contractile force that is required for cell body movement and trailing tail detachment. MLC phosphorylation has also been proposed to control membrane protrusions (41) . Furthermore, we have also found that Ca 2ϩ / calmodulin-dependent protein kinase II, another direct effector of calmodulin, is also required for PDGF-induced MEF cell migration (data not shown). Indeed, in vascular smooth muscle cells, it was claimed that Ca 2ϩ /calmodulin-dependent protein kinase II might be the major mechanism by which Ca 2ϩ modulates cell migration (42) . At the present time, it is not clear what the downstream substrate of Ca 2ϩ /calmodulin kinase II is in the MEF cell migration process. In addition to this increased cytoskeletal contractility, Ca 2ϩ has also been implicated to induce the disassembly of cell substratum adhesion and to activate gelsolin and other Ca 2ϩ -sensitive actin-binding proteins (43, 44) .
The connection between PDGF stimulation and the opening of L-type Ca 2ϩ channels remains to be determined. Similar to those in T lymphocytes (40), L-type Ca 2ϩ channels in fibroblast cells retain their voltage dependence (sensitive to membrane depolarization by KCl). However, the opening of these channels in T lymphocytes and fibroblast cells is controlled by receptor signals. In neurons, stimulation of insulin-like growth factor 1 activates L-type Ca 2ϩ channels through a pathway involving phosphatidylinositol 3-kinase, Akt, and tyrosine kinase Src leading to channel protein phosphorylation (45 (16) . Noticeably, Ca 2ϩ influx-induced trailing tail phosphorylation of MLC was only observed in the migrating cells under high tension, i.e. elongated migrating cells, whereas in the cells with reduced tension, i.e. fan-shaped migrating cells, the trailing tail staining disappeared. Therefore, because of membrane protrusion at the leading edge and strong adhesion at the rear induced by PDGF, the tension increases during migration. Tension, possibly with other signals initiated from PDGF, activates Ca 2ϩ channels, including L-type Ca 2ϩ channels in MEF cells. When the tension reaches a threshold, the trailing tail detaches from the substratum and retracts. Consequently, the decrease in membrane tension leads to the closure of Ca 2ϩ channels and the start of the next round of migration turnover. Alternatively, growth factor signals trigger the opening of Ca 2ϩ channels that lead to the generation of tension.
In migrating MEF cells, there are two areas with strong staining of phosphorylated MLC, post-lamellipodia and trailing tail. A similar bimodal staining pattern of phosphorylated MLC was observed in motile REF-2A fibroblast cells (47) . We have shown that Ca 2ϩ influx-activated MLCK is responsible for the phosphorylation of MLC at the trailing tail, without an effect on the phosphorylation of MLC at the postlamellipodia. Then what is responsible for phosphorylating MLC at the postlamellipodia? Surprisingly, we found that inhibition of Rho kinase blocked the phosphorylation of MLC at the post-lamellipodia, without affecting the phosphorylation of MLC at the trailing tail. 2 As we showed in Fig. 5A , Rho kinase inhibitor Y-27632 actually increased MEF cell migration. These results indicate that the phosphorylation of MLC at the postlamellipodia does not play an essential role for MEF cell migration. It is possible that the phosphorylation of MLC at the postlamellipodia functions in focal adhesion formation (41) . During cell migration, these focal adhesions need to be formed and detached repeatedly. Therefore, Rho kinase inhibitors might enhance this focal adhesion cycle (possibly through the activation of myosin phosphatase), thus leading to a slight increase of cell migration (41) . Focal adhesion turnover is not solely controlled by MLC phosphorylation because abolishment of phosphorylation of MLC (by Rho kinase inhibitors) at the postlamellipodia did not block cell migration.
The fact that inhibition of Ca 2ϩ influx blocked both PDGFand serum-induced cell migration indicates that Ca 2ϩ influx plays a general and essential role for cell migration. Most importantly, we have shown here that blocking Ca 2ϩ influx inhibited the migration of tumor cells (Fig. 2, G and H) . Therefore, inhibitors of Ca 2ϩ influx should be explored as blockers of tumor metastasis in cancer therapies.
FIG. 6. Role of Ca
2؉ influx in phosphorylating MLC at the trailing end of migrating fibroblasts. A, staining of phosphorylated MLC and actin polymers in elongated migrating MEF cells in the presence of serum. There were two areas of phosphorylated-MLC staining in polarized migrating cells (indicated by arrowheads), postlamellipodia staining and trailing tail staining. This distribution of phosphorylated MLC was also assessed by determining the ratio of phosphorylated MLC to total proteins (as measured by Cy5 NHS). B, staining of phosphorylated MLC and actin polymers in fanshaped MEF cells. In these fan-shaped cells, only postlamellipodia staining of phosphorylated-MLC was observed. C, staining of phosphorylated MLC and actin polymers in Ni 2ϩ -treated elongated MEF cells in the presence of serum. The strong postlamellipodia staining of phosphorylated-MLC remained, whereas no trailing tail staining was observed. D, ML-7 (50 M) treatment reduced the staining of phosphorylated MLC at the rear end but had no effect on the staining at the postlamellipodia. Data are representative of three experiments.
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